These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1672622

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells.
    Weerasinghe P, Hallock S, Tang SC, Trump B, Liepins A.
    Exp Toxicol Pathol; 2006 Aug; 58(1):21-30. PubMed ID: 16735106
    [Abstract] [Full Text] [Related]

  • 27. Vinblastine transport by membrane vesicles from human multidrug-resistant CCRF-CEM leukaemia cells: inhibition by taxol and membrane permeabilising agents.
    Syed SK, Christopherson RI, Roufogalis BD.
    Biochem Mol Biol Int; 1993 Jul; 30(4):743-53. PubMed ID: 8104621
    [Abstract] [Full Text] [Related]

  • 28. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
    Hamada H, Okochi E, Watanabe M, Oh-hara T, Sugimoto Y, Kawabata H, Tsuruo T.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7082-7. PubMed ID: 2903793
    [Abstract] [Full Text] [Related]

  • 29. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K, Tsuruo T.
    Cancer Res; 1989 Sep 15; 49(18):5002-6. PubMed ID: 2569930
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B, Prichard RK, Georges E.
    Mol Pharmacol; 1994 Jun 15; 45(6):1145-52. PubMed ID: 7912815
    [Abstract] [Full Text] [Related]

  • 33. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein.
    Bosch I, Dunussi-Joannopoulos K, Wu RL, Furlong ST, Croop J.
    Biochemistry; 1997 May 13; 36(19):5685-94. PubMed ID: 9153408
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
    Smith CD, Carmeli S, Moore RE, Patterson GM.
    Cancer Res; 1993 Mar 15; 53(6):1343-7. PubMed ID: 8095179
    [Abstract] [Full Text] [Related]

  • 38. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells.
    Klohs WD, Steinkampf RW.
    Mol Pharmacol; 1988 Aug 15; 34(2):180-5. PubMed ID: 2901030
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.